ReportWire

Tag: CPROD

  • Analysis: Ukraine’s new weapon will force a Russian shift

    Analysis: Ukraine’s new weapon will force a Russian shift

    [ad_1]

    WASHINGTON/KYIV, Feb 2 (Reuters) – The United States has answered President Volodymyr Zelenskiy’s plea for rockets that can strike deep behind the front lines of the nearly year-long conflict with Russia.

    Now Russian forces will need to adapt or face potentially catastrophic losses.

    The new weapon, the Ground Launched Small Diameter Bomb (GLSDB), will allow Ukraine’s military to hit targets at twice the distance reachable by the rockets it now fires from the U.S.-supplied High Mobility Artillery Rocket System (HIMARS). If included as expected in an upcoming weapons-aid package first reported by Reuters, the 151 km (94 mile) GLSDB will put all of Russia’s supply lines in the east of the country within reach, as well as part of Russian-occupied Crimea.

    This will force Russia to move its supplies even farther from the front lines, making its soldiers more vulnerable and greatly complicating plans for any new offensive.

    “This could slow down [a Russian assault] significantly,” said Andriy Zagorodnyuk, Ukraine’s former defence minister. “Just as HIMARS significantly influenced the course of events, these rockets could influence the course of events even more.”

    Latest Updates

    View 2 more stories

    GLSDB is GPS-guided glide bomb that can manoeuvre to hit hard-to-reach targets such as command centres. Made jointly by SAAB AB (SAABb.ST) and Boeing Co (BA.N), it combines the GBU-39 Small Diameter Bomb (SDB) with the M26 rocket motor, both of which are common in U.S. inventories.

    It is not yet compatible with HIMARS, but the United States will provide Ukraine new launchers for the rockets, said sources. GLSDB could be delivered as early as spring 2023, according to a document reviewed by Reuters.

    VULNERABLE SUPPLY LINES

    When the United States first sent HIMARS launchers in June, it supplied rockets with a 77 km (48 mile) range. This was a major boost for the Ukrainian military, allowing it to destroy Russian ammunition dumps and weapons storage facilities.

    Once Ukraine has the new glide bombs, say military experts, Russia will need to push its supplies even farther away.

    “We are currently unable to reach Russian military facilities more than 80 kilometres away,” said Ukrainian military analyst Oleksandr Musiyenko. “If we can reach them practically all the way to the Russian border, or in occupied Crimea, then of course this will lower the attacking potential of Russian forces.”

    Crucially, Ukraine will soon be able to reach every point of the occupied overland route to Crimea via Berdiansk and Melitopol. That will force Russia to redirect its supply trucks to the Crimean bridge, which was badly damaged in an attack in October.

    “Russia is using Crimea as a big military base from which it sends reinforcements for its troops on the southern front,” said Musiyenko. “If we had a 150km (munition), we could reach that and disrupt the logistical connection with Crimea.”

    Beyond the logistical impact, the addition of a longer-range weapon to Ukraine’s arsenal could help shake Russian confidence.

    Tom Karako, a weapons and security expert at the Center for Strategic and International Studies said that while Ukraine would benefit from an even longer range weapon, GLSDB is “a really important step to give the Ukrainians longer reach and to keep the Russians guessing.”

    NO ATACMS – YET

    For the Biden administration, the decision to send GLSDB to Ukraine represents a step toward meeting Ukraine’s demand for the 185-mile (297km) range Army Tactical Missile System (ATACMS) missile, which the administration has so far declined to provide, fearing a further escalation of the conflict.

    The glide bombs, while not as powerful, are much cheaper, smaller and easier to deploy than ATACMS, making them well suited for much of what Ukraine hopes to accomplish: disrupting Russian operations and creating a tactical advantage.

    Still, said Karako, it is possible the Ukrainians could end up receiving an even longer range weapon in the future.

    “Time and again, we’ve seen the administration say that they would go up to a certain point, but not beyond,” he said. “Then, as the situation has deteriorated, they’ve found the necessity to, in fact, go further.”

    This was the case with HIMARS, the Patriot missile defence system, and, just this month, Abrams tanks, all initially off-limits to Ukraine before the administration ended up approving shipments.

    But for now, the focus will be on how quickly the new glide bombs can arrive in Ukraine, said Zagorodnyuk.

    “If they speed it up…this could hugely change the situation on the field of battle.”

    Editing by Don Durfee and Peter Graff

    Our Standards: The Thomson Reuters Trust Principles.

    [ad_2]

    Source link

  • U.S. FDA allows abortion pills to be sold at retail pharmacies

    U.S. FDA allows abortion pills to be sold at retail pharmacies

    [ad_1]

    WASHINGTON, Jan 3 (Reuters) – The U.S. Food and Drug Administration (FDA) will allow retail pharmacies to offer abortion pills in the United States for the first time, the agency said on Tuesday, even as more states seek to ban medication abortion.

    The regulatory change will potentially expand abortion access as President Joe Biden’s administration wrestles with how best to protect abortion rights after they were sharply curtailed by the Supreme Court’s decision to overturn the landmark Roe v Wade ruling and the state bans that followed.

    Pharmacies can start applying for certification to distribute abortion pill mifepristone with one of the two companies that make it, and if successful they will be able to dispense it directly to patients upon receiving a prescription from a certified prescriber.

    The FDA had first said it would be making those changes in December 2021 when it announced it would relax some risk evaluation and mitigation strategies, or REMS, on the pill, that had been in place since the agency approved it in 2000 and were lifted temporarily in 2021 due to the COVID-19 pandemic.

    The changes included permanently removing restrictions on mail order shipping of the pills and their prescription through telehealth.

    The agency finalized the changes on Tuesday after reviewing supplemental applications from Danco Laboratories and GenBioPro, the two companies that make the drug in the United States.

    “Under the Mifepristone REMS Program, as modified, Mifeprex and its approved generic can be dispensed by certified pharmacies or by or under the supervision of a certified prescriber,” the agency said on its website on Tuesday.

    Mifeprex is the brand name version of mifepristone which, in combination with a second drug called misoprostol that has various uses including miscarriage management, induces an abortion up to 10 weeks into a pregnancy in a process known as medication abortion.

    Abortion rights activists say the pill has a long track record of being safe and effective, with no risk of overdose or addiction. In several countries, including India and Mexico, women can buy them without a prescription to induce abortion.

    “Today’s news is a step in the right direction for health equity,” Planned Parenthood President Alexis McGill Johnson said in a statement.

    “Being able to access your prescribed medication abortion through the mail or to pick it up in person from a pharmacy like any other prescription is a game changer for people trying to access basic health care,” Johnson added.

    NO EQUAL ACCESS

    The regulatory change will, however, not provide equal access to all people, GenBioPro, which makes the generic version of mifepristone, said in a statement.

    Abortion bans, some targeting mifepristone, have gone into effect in more than a dozen states since the U.S. Supreme Court overturned the constitutional right to terminating pregnancies when it scrapped the 1973 Roe v. Wade ruling last year.

    Women in those states could potentially travel to other states to obtain medication abortion.

    The president of anti-abortion group SBA Pro-Life America, Marjorie Dannenfelser, said the latest FDA move endangers women’s safety and the lives of unborn children.

    “State lawmakers and Congress must stand as a bulwark against the Biden administration’s pro-abortion extremism,” she said in a statement.

    FDA records show a small mortality case number associated with mifepristone. As of June 2021, there were reports of 26 deaths linked with the pill out of 4.9 million people estimated to have taken it since it was approved in September 2000.

    Retail pharmacies will have to weigh whether or not to offer the pill given the political controversy surrounding abortion, and determine where they can do so.

    A spokesperson for CVS Health (CVS.N) said the drugstore chain owner was reviewing the updated REMS “drug safety program certification requirements for mifepristone to determine the requirements to dispense in states that do not restrict the dispensing of medications prescribed for elective termination of pregnancy.”

    A spokesperson for Walgreens (WBA.O), one of the largest U.S. pharmacies, said the company was also reviewing the FDA’s regulatory change. “We will continue to enable our pharmacists to dispense medications consistent with federal and state law.”

    Reporting by Ahmed Aboulenein; Additional reporting by Eric Beech in Washington, Shivani Tanna, Rahat Sandhu, and Kanjyik Ghosh in Bengaluru; Editing by Himani Sarkar

    Our Standards: The Thomson Reuters Trust Principles.

    Ahmed Aboulenein

    Thomson Reuters

    Washington-based correspondent covering U.S. healthcare and pharmaceutical policy with a focus on the Department of Health and Human Services and the agencies it oversees such as the Food and Drug Administration, previously based in Iraq and Egypt.

    [ad_2]

    Source link

  • Biden disappointed by ‘shortsighted’ OPEC+ cut, more SPR releases possible

    Biden disappointed by ‘shortsighted’ OPEC+ cut, more SPR releases possible

    [ad_1]

    WASHINGTON, Oct 5 (Reuters) – President Joe Biden called on his administration and Congress to explore ways to boost U.S. energy production and reduce OPEC’s control over energy prices after the cartel’s “shortsighted” production cut, the White House said on Wednesday.

    The Saudi Arabia-led OPEC+ cartel at a Vienna meeting on Wednesday ignored pleas from the White House to keep oil flowing and agreed to cut output by 2 million barrels per day, its deepest cuts in production since the 2020 COVID-19 pandemic.

    The move drew a sharp response from Biden that underscores the growing rift between the United States and Saudi Arabia on energy policy.

    Register now for FREE unlimited access to Reuters.com

    “The President is disappointed by the shortsighted decision by OPEC+ to cut production quotas while the global economy is dealing with the continued negative impact of (Russian President Vladimir) Putin’s invasion of Ukraine,” national security adviser Jake Sullivan and National Economic Council Director Brian Deese said in a statement.

    Biden warned that he will now continue to direct releases from the nation’s Strategic Petroleum Reserve “as necessary,” a shift from the White House’s previous comments that it would end the drawdown in the coming weeks.

    Earlier this year, the Biden administration announced the largest sale ever from the reserve: 180 million barrels for six months beginning in May. Last month it extended that historic sale into November as only about 155 million barrels had been sold. It now aims to sell 165 million through November.

    As a result, the amount of oil in the reserve has fallen to the lowest level since July 1984. It now holds about 416 million barrels of oil, well above what the United States is required by its membership in the International Energy Agency, at sites on the Texas and Louisiana coasts.

    Rising oil and fuel prices are a risk to Biden’s fellow Democrats as they seek to keep control of Congress in the Nov. 8 midterm elections.

    Biden also pledged to consult with Congress on additional tools to cut OPEC’s control over energy prices, a potential reference to a decades-long effort to open the cartel to antitrust lawsuits for orchestrating supply cuts.

    The so-called NOPEC bill, which has brought up numerous times over the past 20 years but never enacted, easily passed a Senate committee in May.

    The White House has previously expressed concerns about unintended consequences of the bill.

    The White House is also worried about the cut cementing Saudi Arabia’s closer cooperation with Russia, also a member of OPEC+, as oil revenues fund Moscow’s war machine in Ukraine.

    “Look it’s clear that OPEC Plus is aligning with Russia with today’s announcement,” White House spokesperson Karine-Jean Pierre told reporters aboard Air Force One on Wednesday.

    Register now for FREE unlimited access to Reuters.com

    Reporting by Susan Heavey and Jarrett Renshaw; editing by Tim Ahmann and David Gregorio

    Our Standards: The Thomson Reuters Trust Principles.

    [ad_2]

    Source link